Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis

Oncology Reports

Volumn 19, Issue 1, 2008, Pages 99-104

  Murakami, Akihiro ^a   Nakagawa, Tatsushi ^a   Fukushima, Chikako ^a   Torii, Mayumi ^a   Sueoka, Kotaro ^a   Nawata, Shugo ^a   Takeda, Osamu ^a   Ishikawa, Hitoshi ^b   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

E cadherin; Lymph node metastasis; Squamous cell carcinoma antigen

Indexed keywords

MONOCLONAL ANTIBODY; SQUAMOUS CELL CARCINOMA ANTIGEN; UVOMORULIN;

ADVANCED CANCER; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CANCER CELL; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CELL FUNCTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; THERAPY EFFECT; UTERINE CERVIX CANCER;

EID: 38749108063     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.1.99     Document Type: Article

References (25)

1. Kato H and Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40: 1621-1628, 1977.
2. De Bruijin HWA, Duk JM, van der Zee AG, Pras E, Willemse PHB, Boonstra H, Hollema H, Mourits MJE, De Vries EGE and Aalders JG: The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumor Biol 19: 505-516, 1998
3. Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, Hui SM and Shilverman GA: A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 92: 3147-3151, 1995.
4. Suminami Y, Kishi F, Sekiguchi K and Kato H: Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Comm 181: 51-58, 1991.
5. Nawata S, Tsunaga N, Numa F, Tanaka T, Nakamura K and Kato H: Serine protease inhibitor activity of recombinant squamous cell carcinoma antigen towards chymotypsin, as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Electrophoresis 16: 1027-1030, 1995.
6. Nawata S, Nakamura K, Tanaka T, Numa F, Suminami Y, Tsunaga N, Kakegawa H, Katunuma N and Kato H: Electrophoretic analysis of the 'cross-class' interaction between novel inhibitory serpin, squamous cell carcinoma antigen-1 and cystein proteinases. Electrophoresis 18: 784-789, 1997
7. Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schechter NM, Pemberton PA and Silverman GA: A squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinase cathepsin G and mast cell chymase. J Biol Chem 272: 1849-1855, 1997.
8. Schick C, Pemberton PA, Shi GP, Kamachi Y, Catalpete S, Bartuski AJ, Gornstein ER, Brömme D, Chapman HA and Silverman GA: Cross-class inhibition of the cysteine proteinases cathepsin K, L, and S by serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37: 5258-5266, 1998.
9. Murakami A, Suminami Y, Hirakawa H, Nawata S, Numa F and Kato H: Squamous cell carcinoma antigen suppresses radiation-induced cell death. Br J Cancer 84: 851-858, 2001.
10. Murakami A, Suminami Y, Sakaguchi Y, Nawata S, Numa F, Kishi F and Kato H: Specific detection and quantitation of SCC antigen 1 and SCC antigen 2 mRNAs by fluorescence-based asymmetric semi-nested reverse transcription PCR. Tumor Biol 21: 224-234, 2000.
11. Gariboldi M, Peissel B, Fabbri A, Saran A, Zaffaroni D, Falvell FS, Spinola M, Tamura J, Pazzaglia S, Mancuso MT, Maurichi A, Bartoli C, Cataltepe S, Silverman GA, Pilotti S, Hayashizaki Y, Okazaki Y and Dragani TA: SCCA2-like serpins mediate genetic predisposition to skin tumors. Cancer Res 63: 1871-1875, 2003
12. Liotta LA: Tumor invasion and metastasis: Role of the extra-cellular matrix. Cancer Res 46: 1-7, 1986
13. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumour dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
14. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M and Mori T: Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 139: 17-23, 1991.
15. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A, Tsukita S and Mori T: E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 54: 291-296, 1994
16. Bowie GL, Caslin AW, Roland NJ, Field JKMA, Jones AS and Kinsella AR: Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol 18: 196-201, 1993.
17. Koseki S, Aoki T, Ansai S, Hozumi Y, Mitsuhashi Y and Kondo S: An immunohistchemical study of E-cadherin expression in human squamous cell carcinoma of the skin. J Dermatol 26: 416-422, 1999.
18. Murakami A, Nakagawa T, Kaneko M, Nawata S, Takeda O, Kato H and Sugino N: Suppression of SCC antigen promotes cancer cell invasion and migration through the decrease in E-cadherin expression. Int J Oncol 29: 1231-1235, 2006.
19. Wu H, Lotan R, Mente D, Lippman SM and Xu XC: Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res 20: 1385-1390, 2000.
20. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W and Funke I: E-cadherin expression in primary and metastatic gastric caner: Down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53: 1690-1695, 1993.
21. Cai Jinhui, Ikeguchi M, Ysujitani S, Maeta M, Liu J and Kaibara N: Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Gastric Cancer 4: 66-74, 2001.
22. Sakuragi N, Nishiya M, Ideda K, Ohkouch T, Furth EE, Hareyama H, Satoh C and Fujimoto S: Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol 53: 183-189, 1994.
23. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeuchi M and Mori T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701, 1993.
24. Jones JL, Raoyall JE and Walker RA: E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer 74: 1237-1241, 1996.
25. Hoshina M, Kimura A, Shibata K, Maruo T and Mochizuki M: Immunocytological distribution of the tumor antigen TA-4: expression during carcinogenesis and maturation of squamous epithelium of human uterine cervix. Asia-Oceania J Obstet Gynecol 12: 119-126, 1986.